Stockscreener 앱 받기
6.70
1.18%
-0.08
시간 외 거래:
6.57
-0.13
-1.94%
전일 마감가:
$6.78
열려 있는:
$6.71
하루 거래량:
5,795
Relative Volume:
0.37
시가총액:
$31.53M
수익:
$5.75M
순이익/손실:
$-38.72M
주가수익비율:
-95.71
EPS:
-0.07
순현금흐름:
$-31.04M
1주 성능:
-6.81%
1개월 성능:
+24.07%
6개월 성능:
-4.39%
1년 성능:
-4.29%
1일 변동 폭
$6.70
$6.89
1주일 범위
$6.70
$7.10
52주 변동 폭
$4.21
$10.97
칼라 파마슈티컬스 Stock (KALA) Company Profile
명칭
Kala Bio Inc
전화
781-996-5252
주소
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
칼라 파마슈티컬스 Stock (KALA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-03-30 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-08-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-09-14 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-07-23 | 개시 | Northland Capital | Outperform |
| 2020-06-01 | 재개 | Oppenheimer | Outperform |
| 2020-05-27 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-09 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | 개시 | Jefferies | Buy |
모두보기
칼라 파마슈티컬스 주식(KALA)의 최신 뉴스
Travis Kalanick | Biography, Uber, & Facts - Britannica
Persistent Corneal Epithelial Defects Pipeline 2024: Clinical - openPR
Persistent Epithelial Defect Market Size is Set for Rapid Growth - openPR
Sunrun (NASDAQ:RUN) Trading Down 5.8% on Insider Selling - Defense World
MPTI Stock Trades Near 52-Week High: Is It Still Worth Buying? - MSN
Here's What Makes Cabot Stock a Solid Choice Right Now - MSN
Here's Why Welltower Stock is an Apt Portfolio Pick for Now - MSN
Broadcom Stock Hits Buy Point On Product News Ahead Of Major Conference - MSN
KALA BIO (KALA) Moves to Strong Buy: Rationale Behind the Upgrade - Yahoo Finance
Dynatrace Shows Improved Relative Strength; Still Shy Of Benchmark - MSN
Brookdale Bets Big With $610M Acquisitions Amid Debt Refinancing - MSN
Toast, Inc. (TOST) is Attracting Investor Attention: Here is What You Should Know - MSN
Oppenheimer Initiates Coverage of Euronet Worldwide (EEFT) with Outperform Recommendation - MSN
Transparency-One’s Kala Hanson Named Recipient of 2024 Women in Supply Chain Award - Yahoo Finance
KALA BIO director resigns from board and committees By Investing.com - Investing.com Australia
KALA BIO director resigns from board and committees - Investing.com
Kala Pharmaceuticals Board Member Mark Blumenkranz Resigns - TipRanks
Kaival Brands’ (KAVL) Stock Surges After Merger Announcement with Delta Corp. - TipRanks
(KALA) Long Term Investment Analysis - Stock Traders Daily
Glazer Capital LLC Trims Holdings in Kairous Acquisition Corp. Limited (NASDAQ:KACL) - Defense World
Kaival Brands Innovations Group Inc. (NASDAQ:KAVL) Stock Makes a Big Move: But Why? - DRP Journal
Celebrities pour in appreciation for Vikky Varun's Kalapatthar - Cinema Express
Market Movers Monday: KAVL, PRSO, TGL, PNPNF, NVVE Surge on Breaking Developments - openPR
Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO), Kaival Brands (NASDAQ: KAVL) among others w/Key Announcements - Barchart
Kaival Brands Shares More Than Double on Delta Corp Holdings Merger - MarketWatch
What's Going On With Kaival Brands Stock Monday? - Benzinga
Kaival Brands Announces Strategic Merger with Delta Corp - TipRanks
Delta Corp Holdings Limited, a Fast Growing Asset-Light Logistics Company Enters into a Definitive Merger and Share Exchange Agreement with Kaival Brands Innovations Group, Inc. - StockTitan
Kayne Anderson Rudnick Investment Management LLC Purchases 15,512 Shares of Kadant Inc. (NYSE:KAI) - Defense World
ProShares Short S&P500 (NYSEARCA:SH) Hits New 12-Month Low at $11.02 - Defense World
Orange (NYSE:ORAN) Trading Down 1.7% - Defense World
Mutual of America Capital Management LLC Has $5.55 Million Stock Holdings in Rexford Industrial Realty, Inc. (NYSE:REXR) - Defense World
Mutual of America Capital Management LLC Reduces Holdings in Occidental Petroleum Co. (NYSE:OXY) - Defense World
Mutual of America Capital Management LLC Boosts Position in Electronic Arts Inc. (NASDAQ:EA) - Defense World
Rhumbline Advisers Raises Position in Reynolds Consumer Products Inc. (NASDAQ:REYN) - Defense World
Sensei Biotherapeutics names new financial chief - Investing.com India
Sensei Biotherapeutics names new financial chief By Investing.com - Investing.com South Africa
KALA BIO (KALA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN
KALA BIO (NASDAQ:KALA) Given “Outperform” Rating at Oppenheimer - Defense World
KALA (Kala Bio) Shares Outstanding (EOP) : 4.60 Mil (As of Jun. 2024) - GuruFocus.com
Financial Review: Lipella Pharmaceuticals (NASDAQ:LIPO) vs. Sagimet Biosciences (NASDAQ:SGMT) - Defense World
Analyzing Trevena (NASDAQ:TRVN) and KALA BIO (NASDAQ:KALA) - Defense World
Aptose Biosciences (NASDAQ:APTO) vs. ImmunityBio (NASDAQ:IBRX) Critical Review - Defense World
Analyzing GlycoMimetics (NASDAQ:GLYC) and Fulcrum Therapeutics (NASDAQ:FULC) - Defense World
KALA (Kala Bio) Profitability Rank : 1 (As of Jun. 2024) - GuruFocus.com
KALA (Kala Bio) Cash Flow from Investing : $9.66 Mil (TTM As of Jun. 2024) - GuruFocus.com
KALA BIO (NASDAQ:KALA) and UroGen Pharma (NASDAQ:URGN) Financial Contrast - Defense World
KALA BIO, Inc. (NASDAQ:KALA) Forecasted to Post Q3 2024 Earnings of ($2.15) Per Share - Defense World
KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - GlobeNewswire
KALA BIO: Q2 Earnings Snapshot - San Antonio Express-News
Chondroitin Market Outlook: Revenue to Climb to USD 1.6 Billion by 2032, Driven by 2.8% CAGR | Future Market Insights Inc. - Future Market Insights
칼라 파마슈티컬스 (KALA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
칼라 파마슈티컬스 주식 (KALA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Kharabi Darius | CHIEF BUSINESS OFFICER |
Jun 26 '24 |
Sale |
4.75 |
5,158 |
24,500 |
59,728 |
| Reumuth Mary | CHIEF FINANCIAL OFFICER |
Jun 26 '24 |
Sale |
4.75 |
4,163 |
19,774 |
60,187 |
| Iwicki Mark T | CHIEF EXECUTIVE OFFICER |
Jun 26 '24 |
Sale |
4.75 |
15,168 |
72,048 |
263,755 |
| Brazzell Romulus K | SEE REMARKS |
Jun 26 '24 |
Sale |
4.75 |
5,489 |
26,073 |
83,982 |
| Bazemore Todd | SEE REMARKS |
May 31 '24 |
Sale |
6.09 |
2,093 |
12,746 |
87,693 |
| Kharabi Darius | CHIEF BUSINESS OFFICER |
May 31 '24 |
Sale |
6.09 |
231 |
1,407 |
64,886 |
| Reumuth Mary | CHIEF FINANCIAL OFFICER |
May 31 '24 |
Sale |
6.09 |
1,786 |
10,877 |
64,350 |
| Brazzell Romulus K | SEE REMARKS |
May 31 '24 |
Sale |
6.09 |
2,002 |
12,192 |
89,471 |
| Iwicki Mark T | CHIEF EXECUTIVE OFFICER |
May 31 '24 |
Sale |
6.09 |
7,392 |
45,017 |
278,923 |
| Trachtenberg Eric | SEE REMARKS |
Jan 04 '24 |
Sale |
6.74 |
1,227 |
8,270 |
68,066 |
2.02%
0.47%
자본화:
|
볼륨(24시간):